Pangea appoints Head of Life Sciences for North America
Geneva, 15 May 2019 – Pangea today announces that it has appointed Dave Mauro to head its North America business as it seeks to grow its presence and ability to support fast-growing business in the region.
Dave Mauro brings significant experience to his role at Pangea. Dave has been building and managing Enterprise Sales Teams for over 25 years, predominantly for global life sciences technology companies such as Cegedim-Dendrite and Sparta Systems. Immediately prior to joining Pangea, Dave was the head of North America Sales for Veeva’s Medical Device & Diagnostics’ R&D Team.
Dave joins at a time of rapid expansion for the company. The Pangea growth platform, which works by providing and empowering the go-to-market resources its clients need to realize their growth, is enjoying very strong momentum. It now operates out of Germany, Switzerland, France, the UK and the US and, as of earlier this month, it extended the breadth of its offering to include both sales and marketing-as-a-service.
Commenting on his decision to join Pangea, Dave Mauro said,
“Pangea is in a unique position to completely disrupt and enhance a commercial model that is in desperate need of innovation. We are harnessing the power of the networked workforce in order provide our clients with a better path to achieve scale. I’m thrilled to be a part of a team that is committed to driving this transformation.”
Marc Baumgartner, Pangea CEO, added,
“In their pursuit of faster growth, more and more companies are realizing that it makes sense to plug into our growth platform. We are delighted to welcome Dave to Pangea whose remit is to build out a team in North America to service both domestic companies, but also firms looking to make a low risk/high return entry in the market.”
Based in Geneva, Pangea is a growth platform, partnering with the world’s most ambitious tech firms to enable them to scale their go-to-market faster and smarter. Our clients range from large enterprises to start-ups across Financial Services, Life Sciences and other fast-growing sectors. And thanks to our global footprint, partner network and deep industry expertise, we can plug our clients into significant network effects to create a virtuous cycle of ever faster growth.